Get a weekly digest of the latest psychedelic research, new studies, and platform updates delivered to your inbox.
No spam, ever. Unsubscribe anytime.
Substance Profile
DOI (2,5-dimethoxy-4-iodoamphetamine) is a potent psychedelic amphetamine and one of the most widely used pharmacological tools in 5-HT2A receptor research. As a radioiodinated compound ([125I]DOI), it serves globally as the standard radioligand for serotonin receptor mapping. The psychedelic effects last 16-24 hours. DOI shows potent anti-inflammatory effects in preclinical studies through 5-HT2A-mediated signaling pathways.
No subjective effects data available yet.
No linked studies yet.